HOUSE DOCKET, NO. 432        FILED ON: 1/10/2019

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 92

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Daniel Cahill

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to improving treatment and continuity of care for patients living with HIV.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Daniel Cahill

10th Essex

1/10/2019

Timothy R. Whelan

1st Barnstable

1/23/2019

Sean Garballey

23rd Middlesex

1/28/2019


HOUSE DOCKET, NO. 432        FILED ON: 1/10/2019

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 92

By Mr. Cahill of Lynn, a petition (accompanied by bill, House, No. 92) of Daniel Cahill, Timothy R. Whelan and Sean Garballey relative to Division of Medical Assistance coverage for the treatment and continuity of care for patients living with HIV.  Children, Families and Persons with Disabilities.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-First General Court
(2019-2020)

_______________

 

An Act relative to improving treatment and continuity of care for patients living with HIV.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1: Section 10J of Chapter 118e of the General Laws, as appearing in the 2016 Official Edition, is hereby amended by inserting after the first paragraph the following new paragraph:-

The division shall provide coverage for drug treatments for antiretroviral regimens used in the treatment of patients with HIV and AIDS that is no more restrictive than the coverage provided by the Massachusetts HIV Drug Assistance Program.  The division shall provide coverage for new antiretroviral regimens approved by the United States Food and Drug Administration no later than 30 days after the final coverage determination by the Massachusetts HIV Drug Assistance Program.  The benefits in this section shall not be subject to utilization management tools, including prior authorization, or step edits for any antiretroviral regimen greater than what is being utilized by the Massachusetts HIV Drug Assistance Program.